Skip to main content

Find Clinical Trials

Home
Conditions
Fibrolamellar Hepatocellular Carcinoma (FLC)

Clinical trial condition

Fibrolamellar Hepatocellular Carcinoma (FLC)

Explore clinical trials studying Fibrolamellar Hepatocellular Carcinoma (FLC). Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Fibrolamellar Hepatocellular Carcinoma (FLC) trial results

Recruiting

Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA

NCT06789198

Conditions: Fibrolamellar Hepatocellular Carcinoma (FLC), Fibrolamellar hepatocellular carcinoma
Locations: University Hospital Tuebingen Tübingen, Germany

Universitätsklinikum Tübingen, Kinderheilkunde I Tübingen, Germany

View Trial Details

Recruiting

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

NCT04248569

Conditions: Fibrolamellar Hepatocellular Carcinoma (FLC), Fibrolamellar hepatocellular carcinoma
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Fibrolamellar hepatocellular carcinoma (2)